Background: There have been conflicting data regarding the risk of sudden cardiac
| INTRODUCTION
Patients with reduced left ventricular ejection fraction (LVEF) due to ischemic or nonischemic cardiomyopathy (CMP) are at increased risk of sudden cardiac death (SCD). Implantable cardioverter defibrillator (ICD) implantation has been shown to reduce SCD rates in these patients. [1] [2] [3] [4] Despite demonstrated benefits, ICD uptake rates have been low. In a tertiary care medical center in the United States, the ICD implantation rate for primary prevention was only 28%. 5 In Singapore, the number of ICD implants for primary prevention has increased 18-fold in a 10-year observational study carried out in a single local large center. 6 Despite this increase, the overall ICD implantation rate in Singapore remains low compared to other developed countries. In 2014 for example, the rate of ICD implantation in Singapore was 52.8 per million. 7 This is in contrast to the rate of In this prospective observational study, we report mortality rates in patients from our local Singaporean population who met current ACC/AHA/HRS criteria for ICD implantation for primary prevention 9 but declined implantation. In addition, we investigate the risk factors for mortality (specifically the presence of comorbidities such as diabetes mellitus, hypertension, hyperlipidemia, chronic kidney disease (CKD), New York Heart Association functional status, LVEF, and age) in this patient cohort to identify high-risk patients who might have benefitted from ICD implantation.
| ME TH ODS
Recruitment of the 240 patients of the National Heart Centre Singapore (NHCS) with ischemic and nonischemic cardiomyopathy with reduced LVEF of ≤35% who had declined ICD implantation has been previously described. 10 The patients were recruited over a 6-month period from analyze patient survival outcomes with adjustment for baseline risk factors. Significance test was two-tailed, and P < 0.05 was considered statistically significant. Statistical analyses were performed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA).
| RESULTS
Clinical characteristics of the 240 patients are provided in Table 1 .
Majority of patients were Chinese (71.3%) followed by Malays Left ventricular ejection fraction, mean ± SD (%) 23 ± 5.9 mortality rates than patients in NYHA class II and higher (P < 0.001; Figure 1A ). Kaplan-Meier analysis showed diabetes mellitus to be a significant risk factor for death (log-rank test, P = 0.011; Figure 1B ).
Patients who had class I indication for ICD had significantly lower survival rates compared to the patients with class IIb indication (logrank test, P = 0.032; Figure 1C ). In the Cox multivariable analysis, the risk of death was higher in patients with diabetes (HR = 1.57; 95% CI, 1.01-2.44; P = 0.047) and in those with CKD (HR = 1.95; 95% CI, 1.17-3.23; P = 0.010). Patients in NYHA class II (HR = 2.15; 95% CI, 1.32-3.50; P = 0.002) and class III (HR = 2.82; 95% CI, 1.34-5.96; P = 0.007) also showed higher risk of death compared to patients in NYHA class I functional status (Table 2) . Gender, baseline LVEF, age, hypertension, hyperlipidemia, and stroke were not significant risk factors for all-cause death.
| DISCUSSION
In our study comprising patients with standard criteria for ICD implantation for primary prevention 9 but declined, the mortality rate was F I G U R E 1 Kaplan-Meier estimates of death stratified by (A) New York Heart Association (NYHA) status showed lower mortality rates for patients in NYHA I compared to NYHA class II and higher (log-rank test, P = 0.0004), (B) the presence of diabetes was a significant risk factor for death for patients with depressed left ventricular ejection fraction who declined implantable cardioverter defibrillator (ICD) (log-rank test, P = 0.0105), and (C) patients who had class I indication for ICD had significantly lower survival rates compared to the patients with class IIb indication (log-rank test, P = 0.032) 13 Morishima et al studied 106
patients in Japan who underwent myocardial perfusion SPECT and who had met MADIT II criteria for ICD implantation. Survival rates were similar to that of the MADIT II conventional group. 14 In a Korean study involving both ischemic and nonischemic CMP patients, the rate of SCD in the Korean patients was comparable to the MADIT II and DEFINITE cohort. 15 The mortality rate in our study was 34.6% over a mean follow-up period of 44.8 ± 16.6 months. This is comparable to mortality rates in the major primary prevention trials.
2-4
A large proportion (93%) of our patients were assessed by their primary cardiologist to be of good functional class status, with 46.7% in NYHA class I and 46.3% in NYHA class II. Only 7% of patients were assessed to be in NYHA class III functional class status. This is in contrast to patients in conventional arm of the MADIT II trial where 39% of patients were in NYHA class I, 34% in NYHA class II, and 23% in NYHA class III. 2 Similarly, a greater proportion of patients enrolled in the SCD-HeFT had poorer functional class status, with 70% in NYHA class II and 30% in NYHA class III functional class. 4 The majority of patients receiving standard therapy recruited in the DEFINITE trial were in NYHA class II (60.7%) with 21.4% NYHA class III and 17.9% NYHA I class status. 3 Compared to the major primary prevention trials, we had a higher proportion of patients assessed by their primary cardiologist to be of good functional status (NYHA classes I and II), and yet mortality rates remained comparable.
Level of class of indication for ICD was shown to be an important factor affecting mortality, with patients who had class I indication for
ICDs having higher death rates in our study. Majority of our patients had class I indication for ICD. This is likely one of contributing factors to our comparable death rates to the major primary prevention trials. This is also an important factor to be considered for physician and patient alike during the discussion for an ICD implantation.
We have shown that diabetes is an independent risk factor for death in this group of patients with depressed LVEF who declined ICD implantation for primary prevention. This finding is consistent with prior studies in diabetic patients with cardiomyopathy. To our knowledge, there has been little South-East Asian data on outcomes in heart failure in patients who declined AICD. Our study provides the only reported local data demonstrating the high mortality rates in a group of patients with depressed ejection fraction and good functional status who declined ICD. Having data closer to home may better convince our patients and aid patients and physicians in making an informed decision regarding uptake of ICDs. From our previous study, the knowledge of depressed ejection fraction with its inherent increased risk of death and of ICDs reducing the risk of mortality was most predictive of patients changing their mind regarding adoption of ICDs. 10 Educational material and time spent by physicians reinforcing this knowledge in a selected group of patients may be well worth in increasing ICD uptake among this group of patients.
Physician due to consideration of overall patient condition is also important in identifying suitable patients for ICD implantation.
Our study is limited by a small sample size, under-representation of female cohort, and it is a purely observational study. There was an overrepresentation of patients in NYHA class I functional status. There was also no control group of matched patients with ICD implantation.
| CONCLUSION
Death rates among patients with depressed EF remain high in our population and are comparable to patients in major ICD primary | 539 prevention trials. Current ICD guideline recommendation for primary prevention is applicable to our local population. The presence of diabetes, CKD, and poorer NYHA status was independent risk factors for death in this group of primary prevention ICD population. Moving forward, identification of novel risk factors in addition to LVEF is of importance in identifying the individuals who may benefit most from ICD implantation.
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